Abstract
Pediatric cholesteatoma can be classified as congenital or acquired based on clinical criteria. We studied the expression patterns of five distinctive cytokeratins in both types of cholesteatoma in order to improve understanding of their pathogenesis and origin. A comparable expression pattern for CK10, CK14, CK18, CK19 and 34βE12 antigens was found in the matrix of congenital and acquired pediatric cholesteatoma. Our results demonstrate that congenital and acquired pediatric cholesteatoma exhibit an identical cytokeratin distribution pattern, suggesting that they share a common origin. Therefore, it seems possible that a portion of the so-called “acquired” cholesteatoma may actually originate from advanced congenital cholesteatoma with secondary destruction of the tympanic membrane in the pediatric patient population.
Similar content being viewed by others
References
Akimoto R, Pawankar R, Yagi T, Baba S (2000) Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 62:257–265
Broekaert D, Boedts D (1993) The proliferative capacity of the keratinizing annular epithelium. Acta Otolaryngol (Stockh) 113:345–348
Broekaert D, Cornille A, Eto E, Leigh I, Ramaekers F, Van Muijen G, Coucke P, De Bersaques J, Kluyskens P, Gillis E (1988) A comparative immunohistochemical analysis of the cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis. Virchows Arch A Pathol Anat 413:39–51
Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D, Leigh I, Lane B (1992) Immunohistochemical analysis of the CK expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 101:931–938
Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E (1993) Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 113:364–368
Chao WY, Huang CC (1989) A immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma. Arch Otorhinolaryngol 246:37–42
Derlacki EL, Clemis JD (1965) Congenital cholesteatoma of the middle ear and mastoid. Ann Otol Rhinol Laryngol 74:706–727
Eichner R, Sun T-T, Aebi U (1986) The role of keratin subfamilies and keratin pairs in the formation on human epidermal intermediate filaments. J Cell Biol 102:1767–1777
Forsen JW (2000) Chronic disorders of the middle ear and mastoid. In: Wetmore RF, Muntz HR, McGill TJ (eds) Pediatric otolaryngology: principles and pathways. Thieme, New York, pp 281–304
Grundfast KM, Ahuja GS, Parisier SC, Culver SM (1995) Delayed diagnosis and fate of congenital cholesteatoma (keratoma). Arch Otolaryngol Head Neck Surg 121:903–907
Hildmann H, Sudhoff H (1999) Cholesteatoma in children. Int J Pediatr Otorhinolaryngol 5 [Suppl 1]: S81–86
Huang J, Yi Z, Lin G (1996) Altered cytokeratin expression of the epidermoid formation of the tympanic cavity of human fetuses. Zhonghua Er Bi Yan Hou Ke Za Zhi 31:72–74
Kasper M, Moll R, Stosiek P, Karsten U (1988) Patterns of cytokeratin and vimentin expression in the human eye. Histochemistry 89:369–377
Kim CC, Chung JW (1990) Morphologic and biologic changes of experimentally induced cholesteatoma in Mongolian gerbils with anticytokeratin and lectin study. Am J Otol 20:13–18
Kim H-J, Tinling SP, Chole RA (2002) Increased proliferation and migration of epithelium in advancing experimental cholesteatomas. Otol Neurotol 23:840–844
Kim HJ, Tinling SP, Chole RA (2002) Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation. J Korean Med Sci 17:381–388
Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H (2001) Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 111:867–873
Koltai PJ, Nelson M, Castellon RJ, Garabedian EN, Triglia JM, Roman S, Roger G (2002) The nature history of congenital cholesteatoma. Arch Otolaryngol Head Neck Surg 128:804–809
Laskiewicz B, Chalstrey S, Gatland DJ, Jones N, Michaels L (1991) Congenital cholesteatoma. J Laryngol Otol 105:995–998
Lee RJ, Sidey C, Narula RA, James RFL (1994) The nature of the epithelium in acquired cholesteatoma: part 3-cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture. Clin Otolaryngol 19:516–520
Levenson M, Michaels L, Parisier C (1989) Congenital cholesteatoma of the middle ear in children. Otolaryngol Clin N Am 22:941–954
Liang JN, Chrobok V, Michaels L, Wright A (2000) Incidence and cytokeratin analysis of the epidermoid formation. Registry 8:1-4
Liang J, Michaels L, Wright A (2003) Immunohistochemical characterization of the epidermoid formation in the middle ear. Laryngoscope 113:1007–1014
Liu J, Rutter MJ, Choo DI, Willging JP (2000) Congenital cholesteatoma of the middle ear. Clin Pediatr 39:549–551
Mansbridge JN, Knapp AM (1987) Changes in keratinocyte maturation during wound healing. J Invest Dermatol 89:253–263
Mare SD, Jong ED, Van Erp PEJ (1990) Markers for proliferation and keratinization in the margin of the active psoriatic lesion. Br J Dermatol 122:469–475
Michaels L (1986) An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J Otolaryngol 15:169–174
Michaels L (1988) Evaluation of the epidermoid formation and its role in the development of the middle ear and tympanic membrane during the first trimester. J Otolaryngol 17:22–28
Moll R, Franke WW, Schiller DL (1982) The catalog of human CK: patterns of the expression in normal epithelia, tumors and cultured cells. Cell 31:11–24
Nelson M, Roger G, Koltai PJ, Garabedian EN, Triglia JM, Roman S, Castellon RJ, Hammel JP (2002) Congenital cholesteatoma. 128:810–814
Potsic WP, Korman SB, Samadi DS, Wetmore RF (2002) Congenital cholesteatoma: 20 years’ experience at the Children’s Hospital of Philadelphia. Otolaryngol Head Neck Surg 126:409–414
Ramaekers F, Huysman A, Moesker O, Kant A, Jap P, Herman C, Vooijs P (1983) Monoclonal antibody to keratin filaments specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest 49:353–361
Rashad U, Hawthorne M, Kumar U, Welsh A (1999) Unusual cases of congenital cholesteatoma of the ear. J Laryngol Otol 131:52–54
Rosenfeld RM, Moura RL, Bluestone CD (1992) Predictors of residual-recurrent cholesteatoma in children. Arch Otolaryngol Head Neck Surg 118:384–439
Sade J (1971) Cellular differentiation in the middle ear lining. Ann Otol Rhinol Laryngol 80:376–384
Sanna M, Zini C, Scandellari R, Jemmi G (1984) Residual and recurrent cholesteatoma in closed tympanoplasty. Am J Otol 5:277–282
Sheehy JL (1978) Management of cholesteatoma in children. Adv Otorhinolaryngol 23:58–64
Shinkawa H, Hozawa J, Usami S, Saito (1993) Immunohistochemical study on CK and vimentin expression in congenital cholesteatoma. In: Nakano Y (ed) Cholesteatoma and mastoid surgery. Kugler, Amsterdam, pp 155–166
Shohet JA, de Jong AL (2002) The management of pediatric cholesteatoma. Otolaryngol Clin N Am 35:841–851
Sobol SM, Reichert TJ, Faw KD, Stroud MH, Spector GJ, Ogura JH (1980) Intramembranous and mesotympanic cholesteatomas associated with an intact tympanic membrane in children. Ann Otol Rhinol Laryngol 89:312–317
Sun TT, Eichner R, Nelson WG, Tseng SCG, Weiss RA, Jarvinen M, Woodcock-Mitchell J (1983) Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 81:109s–115s
Sun TT, Tseng SCG, Huang AHW, Cooper D, Schermer A, Lynch MH, Weiss R, Eichner R (1985) Monoclonal antibodies studies of mammalian epithelial keratins: a review. Ann NY Acad Sci 455:307–329
Sudhoff H, Hildmann H (2003) Current theories on the origin of cholesteatoma. HNO 51:71–82
Sudhoff H, Tos M (2000) Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory. Am J Otol 21:786–792
Sudhoff H, Liang J, Dazert S, Borkowski G, Michaels L (1999) Zur Rolle der Epidermoid Formationen in der Pathogenese des kongenitalen Cholesteatoms—eine aktuelle Übersicht. Laryngorhinootologie 78:63–67
Teed RW (1936) Cholesteatoma verum tympani: its relationship to the first epibranchial placode. Arch Otolaryngol 24:455–474
Thewes M, Stadler R, Korge B, Mischke D (1991) Normal psoriatic epidermis of hyperproliferation-associated keratins. Arch Dermatol Res 283:465–471
Tseng SCG, Jarvinen MG, Nelson WG, Woodcock-Mitchell J, Sun TT (1982) Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 30:361–372
van Blitterswijk CA, Grote JJ, Lutgert RW, Hesseling SC, Out CJ, Van Muijen GN, Fransen JA (1989) Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Ann Otol Rhinol Laryngol 98:635–640
Vennix PP, Kuijpers W, Peters TA, Tonnaer EL, Ramaekers FC (1996) Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes. Arch Otolaryngol Head Neck Surg 122:825–832
Weiss RA, Guillet GYA, Freedberg IM, Farmer ER, Small EA, Weiss MM, Sun TT (1983) The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. J Invest Dermatol 81:224–230
Weiss RA, Eichner R, Sun T (1984) Monoclonal antibody analysis of keratin expression in epidermal disease: a 48- and 56-k dalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 98:1397–1406
Wolfman DE, Chole RA (1986) Experimental retraction pocket cholesteatoma. Ann Otol Rhinol Laryngol 95: 639–644
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olszewska, E., Lautermann, J., Koc, C. et al. Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma. Eur Arch Otorhinolaryngol 262, 731–736 (2005). https://doi.org/10.1007/s00405-004-0875-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-004-0875-0